Pharma Journalist

Healthcare Market Access & Pricing World Summit
2019-05-28 - 2019-05-29 | NH Frankfurt Airport West Kelsterbacher Str. 19, 65479 Germany
The 2nd annual Healthcare Market Access & Pricing Summit is the meeting place for the Healthcare Pricing, Market Access, Reimbursement, HEOR, and RWE community.
Senior level experts from companies such as Abbott, Merck, Allergan, and Johnson & Johnson among others will give you valuable insights through various interactive sessions.
With hot session topics like biosimilars, orphan drugs and rare diseases, this conference will provide a total and complete insight into the latest developments in the healthcare space, may it be Pharma, MedTech, Biopharma or Biotech.
Join over 60+ healthcare professionals in May, and book your ticket now!

Microbiome Invest
2019-05-23 | London (Venue TBC)
Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.

RE•WORK Deep Learning in Healthcare Summit, Boston
2019-05-23 - 2019-05-24 | InterContinental® Boston, 510 Atlantic Avenue, Massachusetts 02210
The Deep Learning in Healthcare Summit is returning to the east coast for the annual event in Boston! Hear from healthcare industry leaders, academics, researchers, and innovative startups working to advance deep learning technology and apply this within the health sector. Focusing on topics such as medical imaging, diagnostics, personalized medicine and how these are applied within pharmaceuticals, patient care, and health and wellbeing. The summit is a great way to discover the latest insights, evaluate your position within the industry and learn how the impacts can affect yourself and your work and provides an opportunity to network with other valued members of the community.
Discount Code: MP20

5th Precision CRISPR Genome Editing Congress
2019-05-21 - 2019-05-23 | The Westin Boston Waterfront, 425 Summer Street, Boston, MA, 02210, United States
Designed with CRISPR experts from AstraZeneca, AbbVie, Broad Institute, Casebia, Merck, Amgen and academics worldwide, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery, safety, precision, and efficiency to further optimize the relevant areas of drug discovery, functional screening & CRISPR-based cell & gene therapy.

Learn about how CRISPR is working in a clinical setting and unique approaches to gene therapy
Discover advances in disease modeling and strategies improving validation of human biology
Understand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox
Explore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases
Discover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline
Participate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR

With 100+ thought-leaders converging, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network.
To learn more about this event, visit https://ter.li/tjkmgn

NDD Europe 2019
2019-05-21 - 2019-05-23 | Hilton Paris La Defense, 2 Place de la Défense, 92800, Puteaux, France, France
Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics

Multiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success.
NDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers.
With 70+ thought-leaders converging at NDD Europe, this will be an unrivalled opportunity for you to gain the latest scientific insights, have your peers review your research and grow your collaborator network.

3rd Annual Digi-Tech Pharma 2019
2019-05-21 - 2019-05-22 | London, United Kingdom
Our upcoming conference 3rd Annual Digi-Tech Pharma 2019 (Pharmaceutical technology conference 2019), will provide a platform to all its participants an opportunity to interact, share and discuss the digitalization of Pharma industry. The conference will allow its participants to discuss the various challenges faced, new strategies, case studies and use of innovative ideas in the field of Digital Pharma IT. Also, to stay updated on the latest trends in digital, social media and mobile strategies required to overcome the obstructions in the transformation. This Digi-Tech Pharma 2019 is a unique platform in the pharmaceutical conferences which will allow IT leaders to share their technologies and strategies to help the pharma industries avail new opportunities to encourage partnerships and collaborations.

TIDES: Oligonucleotide & Peptide Therapeutics
2019-05-20 - 2019-05-23 | Manchester Grand Hyatt | San Diego, CA
TIDES is the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

1000+ Oligonucleotide & Peptide Scientists and Executives
Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.
90+ Exhibitors
Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.
125+ Case Studies and New Data Presentations
Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.
Register now at www.TIDESEvent.com with code “PHARMJ10” and SAVE 10%.

Plant Genomics and Gene Editing Congress: Europe
2019-05-20 - 2019-05-22 | Rotterdam, The Netherlands Postilion Convention Centre WTC Rotterdam, Rotterdam, Netherlands
Global Engage is pleased to announce the 7th Plant Genomics & Gene Editing Congress: Europe, taking place 21st-22nd May 2019, in Rotterdam, The Netherlands. This event is part of our widely-regarded Plant Genomics Series which includes an Asian and US meeting each year.
Attracting over 300 experts working in all areas of plant science, this event will examine the latest in gene editing methods for plant genomics research. CRISPR/Cas9 case studies and the very best strategies for plant genome engineering will be presented by industry leaders, experts, and pioneering academics at the forefront of plant research. Developments in gene editing, NGS, and omic technologies will all be explored for crop trait development, disease resistance, epigenetics, plant breeding, and more. Tracks dedicated to plant & soil microbiomes, and the importance of plant phenotyping in the context of bioinformatics challenges, will encourage a holistic approach to plant research; the former will focus on identifying microbes to enhance crop productivity & disease resistance, while the latter will showcase the best tools for overcoming bioinformatics bottlenecks, applicable to plant research across the board. We will also be looking to examine the impact of the ECJ’s latest interpretation of GMO regulations, and what this means for the future of gene editing research, addressing issues such as how to navigate the new legislation, and considering what alternative strategies & technologies there might be for progressing plant genomics.

Microbiome & Probiotics Series: Europe
2019-05-20 - 2019-05-22 | Rotterdam, The Netherlands Postilion Convention Centre WTC Rotterdam, Rotterdam, Netherlands
Part of the leading global microbiome and probiotics conference series, the 2019 European event will bring together more than 400 industry, academic, and investment leaders to discuss the must cutting-edge microbiome and probiotics research, challenges and opportunities in moving research towards commercialisation, and potential partnerships and collaborations.
For the first time, this event will be three days. As an attendee, you will get more in-depth content on the key challenges and topics facing researchers and product developers, and more time to establish partnerships. Hear from top scientists in the field, meet willing investors and collaborators, and learn about exciting new companies in the microbiome space. With ample networking time and interactive sessions like the roundtable discussions, there will be many opportunities to broaden your connections.

Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress
2019-05-20 - 2019-05-21 | Dublin, Ireland, Hotel Riu Plaza The Gresham Dublin, Dublin, Ireland
This comprehensive two-day congress features 30 presentations given across four tracks. It will provide experts with an exceptional environment in which to examine the key developments occurring today. Topics covered includethe automation of vaccine formulations, purification technologies, T-cell manufacturing and glycoanalytic technologies.

SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
2019-05-15 - 2019-05-16 | Copthorne Tara Hotel London Kensington, Copthorne Tara Hotel London Kensington, London, SW7 4DN, United Kingdom
The SMi Group is pleased to announce the second annual Injectable Drug Delivery conference which will be held in London on the 15th and 16th May 2019.
The global injectable drug delivery market is expected to grow from $400 billion to $1200 billion by 2046 with a CAGR of 12.8%.

Injectable drug delivery is a method of drug administration into the body with a needle via various routes including intramuscular and intravenous. These are examples of conventional drug delivery. Recently, there has been a focus on novel drug delivery, including needle-free injectors, and transdermal patches. Long acting injectables (LAI) are developing fast as a push towards patient centric devices drives the industry. Habitually, injectables were used for delivery of hormones, vaccines and insulin but as technology advances the application is continuing to expand. Now there is an emphasis on finding solutions to chronic conditions and the biological drugs required involve formulation development challenges for proteins, including high viscosity and high volume. Self-administrative, connected, and ergonomic devices are the new drive. Self-injectable devices include pen injectors for diabetic patients. The wealth of expansion available in the field of connected devices is huge. The regulatory landscape is challenging as it evolves rapidly with the market demand for new devices.
The benefits of attending:
Developing on last year’s success, this event assembles an international audience to include regulatory, device design, packaging and formulation professionals. The devices need to be designed for the new generation of drugs and they need to provide safety with a strong patient focus. This event is will help inspire you to help drive this industry forward and learn about the predicted market trends, critical digital and chemical developments and the push for patient compliance in a changing regulatory landscape.
This conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following:
– Life cycle management for developing devices that are both user friendly and revenue effective
– Device design considerations
– Long acting injectables and bringing these therapeutics to market with case studies
– Connected devices, GDPR and cyber security programs
– Developments in primary packaging
– Growth in transdermal delivery and subcutaneous infusion devices
– Digital health partnerships
– Large volume patch pump innovation examples
Who should attend
Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of:

Autoinjectors
Wearables
Device Engineering
Human Factors
CMC
Injectables
Sterile Manufacturing
Packaging
Regulatory Affairs

Featured Speakers:

Bjorg K. Hunter, Device Engineering Manager, GSK
Miranda Newbery, Human Factors Consultant, Inspired Usability
Blake Green, Regulatory Affairs Senior Manager, Devices, Amgen
Quentin Le Masne, Head of Engineering team – Electro-Medical / Drug Delivery Devices, Merck
Vasco Filipe, Formulation and Drug Process Development Section Head for Biologics, Sanofi
Stephen Paboojian, Senior Project Leader I for Device Development, Novartis
Tom Lawrie-Fussey, Digital Services Specialist, Cambridge Design Partnership
Terry Reed, Director of Business development, AstraZeneca
Joel Richard, Head of Technical and Pharmaceutical Operations, MedinCell

*Plus, pre-conference workshops – 14th May 2019
EARLY-BIRD RATES:

BOOK BY 31st JANUARY AND SAVE £400
BOOK BY 28th FEBRUARY AND SAVE £200
BOOK BY 29th MARCH AND SAVE £100

LinkedIn: @SMi Pharma
Twitter: @SMiPharm #SMi
To learn more about this event, and to register online, visit www.injectable-drug-delivery.com/pharmajwl

GLOBAL CLINICAL TRIALS CONNECT 2018 (Collaboration, Innovation And Enhancing Quality In Clinical Trials )
2019-05-08 - 2019-05-09 | London, United Kingdom
The Global Clinical Trials Connect 2019 conference focuses on introducing pioneer technology, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency. This conference will bring together the industry experts and leaders across pharmaceutical, biotechnological and CRO’s for brainstorming on Case studies on innovation, collaboration and existing clinical data to headway the Clinical Trials process. Ethical considerations are given in this context and for this RBM are beginning to extend its concepts in Quality Risk Management; clinical trial predictive models are accumulated by enterprises, methodologies in trial design and many more.

Extractables & Leachables USA 2019
2019-05-07 - 2019-05-09 | Westin Arlington Gateway – 801 N Glebe Rd, Arlington, VA 22203, United States
Extractables & Leachables USA brings together leading E&L experts and decision makers from across the supply chain to get the latest updates on regulations, best practices, safety compliance, biocompatibility, advancements in the sector, working group updates, and much more. Taking place May 7-9, 2019, at the Westin Arlington Gateway in Arlington, Virginia – this event offers the unique opportunity to make new connections, network with peers, share new information, and discuss the key topics, trends, and new industry developments that are affecting the E&L marketplace. Use code PHARM19 to SAVE 15% off the current ticket price!

2nd Annual CKD3 Summit
2019-05-06 - 2019-05-08 | Revere Hotel Boston Common, 200 Stuart St, Boston, MA, 02116, United States
Chronic Kidney Disease Drug Development (CKD3) is a uniquely focused conference that unites key opinion leaders in this field to identify and discuss the critical factors determining the success of current CKD pipelines and significantly impact the standard of care for this huge unmet medical need.

Bringing together leading experts from innovative biotechs, large pharma, academia and key service provider companies, CKD3 will present comprehensive insight into the cutting edge progress of CKD drug development research.
To learn more and to register online, visit https://ter.li/10so2k

Clinical Operations in Oncology Trials to the West Coast 2019
2019-04-30 - 2019-05-01 | Burlingame, California
Arena International is excited to announce the return of the 6th Annual Clinical Operations in Oncology Trials to the West Coast on April 30th – May 1st 2019.
As one of the only oncology operationally focused events in the West Coast, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage West Coast physicians and patients.
The event will be led by a myriad of industry specialists from the West Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion, spotlight Q&As, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market.
While maintaining the primary focus of its previous years, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry, and provide insight into the latest technological and therapeutic solutions.
We hope to see you in April, make sure to register your place today!

European NeoAg Summit
2019-04-23 - 2019-04-25 | Amsterdam Marriot Hotel Stadhouderskade 12, 1054 ES Amsterdam, Netherlands
With an exclusive case-study led agenda, the European NeoAg Summit will paint a fuller picture of neoantigen presentation and T-cell interaction. Hear updates on clinical trials results to help you further determine neoantigen immunogenicity.
In addition, gain practical insights on personalised cancer vaccine and cell therapy global clinical development, as well as regulatory guidance.
Join the gathering of over 100 personalised cancer immunotherapy pioneers from pharma and biotech including Ziopharm, Genocea, Vaccibody and more to advance neoantigen based cancer vaccines and cell therapies.
For more information, visit www.neoantigen-europe.com

Neuroimmunology Drug Development Summit (NIDD)
2019-04-16 - 2019-04-18 | Hyatt Regency Boston One Avenue de Lafayette, Boston Massachusetts, United States, 02111
Built with thought-leaders at Sanofi, Eisai, AbbVie and Denali, the inaugural NIDD Summit will share the field’s cutting-edge scientific advances enabling you to translate your neuroimmunology research into a clinically effective therapeutic for neurological diseases.

With an emphasis on neurodegeneration, chronic neuroinflammatory mechanisms will be explored whilst addressing your drug development challenges:

Discover robust biomarkers of neuroinflammation to enable successful translation and patient stratification
Navigate preclinical model limitations to better predict clinical efficacy
Explore the identification and validation of neuroimmunological targets and assess novel therapeutic approaches

Don’t miss this opportunity to learn from 20+ industry expert speakers to effectively target neuroimmunological mechanisms and rapidly progress your research to the clinic.
For more information, visit www.neuroimmunology-drugdevelopment.com

CAR-T Congress USA
2019-04-16 - 2019-04-17 | Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, MA, 02128, United States
CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy.

The fourth annual CAR-T congress USA provides a platform for emerging novel data in small scale clinical trials ran by the leading academic institutions, including MD Anderson and the University of Pennsylvania.
Hear first-hand, the emerging areas of research from new companies into single patient experiences, as well as context around patient relapses and methods of toxicity management.
Join thought leaders from biotechs, pharmaceutical companies and academia to address the challenges of CAR-T therapy including toxicity, scalability and efficacy in both liquid and solid tumours.
Discover how CAR-T compares to standard treatments and advances in genome editing tools, the new methods in allogeneic and autologous process development and the pre-clinical concepts that will pave the way for novel antigen discovery.
Be part of the movement that engineers a strategy to reprogram the cancer treatments we know today.
Book before January 25 to save up to $800. To learn more about this event and to book online visit: www.car-tcongress.com/register

17th annual eyeforpharma Philadelphia Conference
2019-04-16 - 2019-04-17 | Pennsylvania Convention Center, 1101 Arch St, Philadelphia, PA, 19107, United States
Where pharma’s performance is built by patient value
The world’s greatest gathering of pharma’s value-designers
Every important industry player in one room, evolving our antiquated model by embracing value-based care. That’s the vision for eyeforpharma Philadelphia, the flagship event where pharma, patients and payers co-design for outcomes.
There are dozens of events on digital, on patient centricity, on data, on access, on medical, on commercial. Only one event brings all the key designers together so that we can address unmet need, create solutions that cover the spectrum, and end the age-old problems of misalignment.
Join us for pharma’s most influential meeting – as we write the blueprint for healthcare’s future.
To learn more about this event, and to register online, visit http://bit.ly/2O8ldd5

Adaptive Designs in Clinical Trials 2019
2019-04-01 - 2019-04-02 | Holiday Inn Kensington Forum, 97 Cromwell Road, London, SW7 4DN, United Kingdom
SMi Group are proud to announce the 11th annual Adaptive Designs in Clinical Trials conference and exhibition will return to London from the 1st – 2nd April 2019. With the growing popularity in use and acceptance of adaptive designs in clinical trials – demonstrated most recently with the new FDA draft guidance on adaptive designs – there is a pressing need for a forum which explores this increasingly normalized medical methodology.

Hosting in depth presentations from regulatory agencies, researchers and biostatisticians, the meeting will cover how personalized medicine, platform trials, response-adaptive randomization, signature designs, estimand framework, Bayesian methods and digital innovation are revolutionizing the drug development process both in Europe and North America.
To learn more and to register online, visit www.adaptivedesigns.co.uk/pharmajwl

The Pharma Gorilla
2019-03-27 | Hilton Mumbai International Airport, Mumbai, India
The Pharma Gorilla will be held on March 27, 2019 in Hilton Mumbai International Airport, Mumbai, India. It provides the opportunity to learn, engage and network for the pharmaceutical and healthcare fraternity. This conference is designed to address practical issues and topics for Corporates, scientists, professors, business representatives, and healthcare providers to discuss the latest innovations, trends and concerns, practical challenges and solutions in Pharma.
The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends, advancements, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry.
The Pharma Gorilla provides a perfect platform for conducting presentations, keynote sessions, sharing the knowledge, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.

Clinical Trial Supply New England 2019
2019-03-26 - 2019-03-27 | Boston, Massachusetts
This year’s Clinical Trial Supply New England celebrates its 8th year and will be hosted on the 26th – 27th of March.
In 2019 we have worked hard to prepare a leading industry agenda which makes this event a must attend in the industries calendar. We have built on last year’s success conference and are returning with full force to Boston with the aim of supporting trial sponsors and solution providers across New England to ensure trials are delivered on time, partnerships are improved and supply chain uncertainties are resolved.
We will once again be meeting in to discuss, deliberate and debate the latest operational and technological challenges with regards to clinical trial supplies. Over the course of two days you can expect to catch-up with old colleagues and make new lasting business connections to help drive success in your trials. As Arena’s dedicated Clinical Trial Supply conference for the New England area, this event caters to local needs while offering the change to meet international sponsors and solution providers.
At each Clinical Trial Supply conference we create a welcoming networking environment and an educational program packed with the latest case studies, techniques and providers to set your trial apart. This year is no different as we have a vast array of fascinating case-studies, thought leading presentations and engaging panels.
This year we will be looking at those issues which are affecting companies in the Boston-Cambridge hub, such as but no limited to: ways to move beyond the theory; harnessing the power of technology to design a functioning Direct to Patient (DtP) supply chain, discovering how to incorporate gene therapies within your supply chain and blockchain: a discussion of practical applications for clinical supply chain and life-sciences.
With such a packed program you can’t afford to miss out. We look forward to meeting you in Boston so make sure to book your place today!

Gene Therapy for Rare Disorders
2019-03-26 - 2019-03-28 | The Westin Boston Waterfront, 425 Summer St, Boston, MA, 02210, United States
Gene Therapy for Rare Disorders is a uniquely focused conference that unites the leaders in the field to identify and discuss the critical factors that will influence genetic treatments most significantly in the near future.

Incorporating insights from 50+ industry-leading speakers, the meeting delves into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.
Bringing together leading experts from innovative biotechs, large pharma, academia and key service provider companies, Gene Therapy for Rare Disorders will present a comprehensive insight into the cutting edge progress of gene therapies combatting rare disease.
Join 350+ of your colleagues to accelerate the progress of the next generation of gene therapies that show improved efficacy, enhanced safety and commercial viability.
To learn more and to register online, visit https://bit.ly/2ByuEe2

Innate Killer Summit 2019
2019-03-19 - 2019-03-21 | Hilton San Diego Gaslamp Quarter, 401 K St, San Diego, CA 92101
Accelerate to Market Genetically Engineered, Off-the-Shelf and Cost Effective NK Cell Immunotherapies for Solid Tumor Indications
The Innate Killer Summit 2019 discusses safer, more cost-effective and potentially more efficacious NK cell immunotherapy as the next generation of frontline cancer therapy.

It will help you to optimize your manufacturing and process development strategies to further reduce the cost of off-the-shelf NK cell therapies. Discuss the most up to date clinical data on genetically engineered NK cells from CARs to bispecific engagers and ensure persistence and durability.
Bringing together over 100 of the field’s leading minds to share experience and knowledge on the optimal NK cell source and improve the efficacy of NK cell therapies through enhanced targeting methods. Join us at the 4th Annual Innate Killer Summit to bring to patients the next generation of cell immunotherapies that are safer and cheaper.

Pharma Security World 2019 - Anti-Counterfeiting, Drug Serialization and Supply-Chain Security Conference
2019-03-19 - 2019-03-20 | London, United Kingdom
The Counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores. What’s more, pharmaceutical companies and regulators are creating ways to stop them. No nations stay untouched by this issue, what was once viewed as an issue endured by developing nations has now turned into an issue to developing nations including US and Europe. We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters. To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Security World 2019 – Supply-Chain, Drug Serialization and Anti-Counterfeiting Conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas and the conference will also offer opportunities to encourage partnerships and collaborations.

ePharma IMPACT
2019-03-19 - 2019-03-21 | NY Hilton 1335 Ave of the Americas New York, NY 10017, NY, United States
ePharma IMPACT brings together the most influential players across the digital marketing spectrum to reveal truly innovative, next generation omni-channel strategies.
The 3-day event is designed to help you take command of the most influential strategies on the horizon so you can confidently determine where your next digital marketing dollar should be spent for maximum impact.
How do we deliver on that promise? By offering a diversified experience like you won’t find anywhere else. One that translates directly into stronger patient and HCP relationships, and greater influence over impactful marketing strategy.
The 12th annual conference is THE event leading pharma companies rely on to stay ahead of digital disruption and translate digital marketing strategies into bottom line impact.

ProcureCon Pharma 2019
2019-03-19 - 2019-03-20 | Steigenberger Frankfurter Hof, Am Kaiserplatz, Frankfurt/Main, 60311, Germany
Taking place on 19th-20th March 2019 in Frankfurt, ProcureCon Pharma is the only Conference for CPOs & Senior Procurement Executives from leading pharma Companies

Join 150+ senior procurement professionals from Merck, AstraZeneca, Roche, Sanofi, Lonza and other world leading Pharma businesses over 2 days and 40 interactive sessions that will help you make better outsourcing decisions, speed up transformation and co-create value with business partners. To learn more about ProcureCon Pharma, download the agenda.
Take away solutions to all of your top challenges:

Master analytical and digital procurement in pharma
Build strategic partnerships with your internal stakeholders
Design and train a high-performing global pharma procurement team
Move beyond savings with key CROS and CMOS to unlock hidden innovation

For more information including the incredible speaker line-up, take a look at the conference brochure here: https://bit.ly/2yIP6a1
Book your place online today: https://bit.ly/2PvKzS8 and get 15% off the current ticket price with our exclusive discount code – “PCPPJ15”

3rd Annual Drug Discovery Chemistry
2019-03-18 - 2019-03-19 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi’s 3rd Annual Drug Discovery Chemistry
Developing your R&D pipeline with strategies to deliver small molecules
Conference: 18 – 19 March 2019
Workshop: 20 March 2019
Location: Copthorne Tara Hotel, London, UK
Website: www.drug-discovery.co.uk/PJwl
CHAIRED BY:
Roderick Hubbard, Senior Fellow, Vernalis Research Ltd
Darren Green, Director of Molecular Design, GSK
SMi is proud to present its 3rd Annual Drug Discovery Chemistry event, taking place on the 18th-19th March 2019.

The fight to optimise the drug discovery process is on as there is currently a reduced output of new medicines within the market, however, demand for novel drugs is still steadily increasing.M
This year’s event will specifically focus on innovations within the field that has the potential to drive the pharmaceutical industry into a new era of medicines, with optimization of the R&D process to become cheaper, faster and increasing the likelihood of drug efficacy and success. These are some of the major obstacles within drug discovery at present, as the process is overall long, expensive and often potential drugs will fail late in clinical trials, wasting resources and time.
The event will also focus on novel techniques that can be implemented within the field today that can identify new druggable targets and possibly open new therapeutic areas within the clinic. This could offer opportunities for pharmaceutical companies to produce medicines for diseases and ailments that have previously not been targeted, and likewise, offer new drug targets for existing diseases that could potentially offer better clinical outcomes, such as within the development of cancer drugs.
Drug Discovery Chemistry 2019 will look at various developments within the field, guiding companies on how they can best utilize the newest technologies and drug discovery modalities to develop new medicines, reduce their R&D cost and timelines, and ultimately, increase their medicine output for commercial success.
Event Hashtag: #SMiDrugDisChem
KEY SPEAKERS INCLUDE:

Vivek Vishnudas, Senior Vice President Drug discovery & Platform Sciences, Berg LLC
Tobias Gabriel, Global Head of Discovery Chemistry, Novartis
Govinda Bhisetti, Principal Investigator and Head of Computational Chemistry, Biogen
Hasane Ratni, Expert Scientist, F Hoffmann-La Roche
Alexander Hillisch, Director of Medicinal Chemistry, Bayer

KEY TOPICS FOR 2018 INCLUDE:

Discuss the impact of the use of novel computational techniques on R&D pipelines
Hear about the progress in the development of new drugs on difficult targets and how these can revolutionise patient treatment
Discover how AI is being utilised in the commercial setting and opportunities to best exploit these to streamline the Drug Discovery Process
Explore the potential of new modalities to transform therapeutics
Learn about current strategies to increase drug discovery success

Post conference workshop on 20 March 2019
Artificial Intelligence in Drug Discovery
Led by: Nick Camp, Consultant
WHO SHOULD ATTEND
CEOs, Presidents, Vice Presidents and Global Heads, Executive Directors, Vice President & Global head, Principal Scientists, Heads of Business Development, Directors of Pharma/Biotech firms.
EARLY BIRD-RATES

BOOK BY 30 NOVEMBER AND SAVE £400
BOOK BY 15 DECEMBER AND SAVE £200
BOOK BY 31 JANUARY AND SAVE £100

21st Annual Superbugs & Superdrugs Conference
2019-03-18 - 2019-03-19 | HOLIDAY INN KENSINGTON FORUM, 97 Cromwell Road, London, SW7 4DN, United Kingdom
As the global threat of antimicrobial resistance continues to grow, the advances of modern medicines are at risk of being lost. Failure to act quickly means the spread of antibiotic-resistant bacteria could lead to increased mortality from normally minor injuries and benign infections.

SMi’s highly anticipated Superbugs & Superdrugs conference is set to return to London, UK for its 21st year running, on the 18th & 19th March 2019. This year’s event aims to provide valuable insights and key updates on the latest developments within the scientific communities, as well as the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.
The two-day conference will also host a diverse gathering of policy makers and economists, in addition to big pharmas and biotechs, who will discuss incentives, partnerships, regulations and new policies. Industry experts and scientific pioneers are set to present on their research advances and clinical data, as well as alternatives to antibiotics, such as monoclonal antibodies and antimicrobial peptides.
2019 HIGHLIGHTS:

Analyse the current status of antimicrobial resistance with industry-led insight into current strategies to tackle AMR
Hear about novel immune-therapeutics to target Gram-negative bacterial infections
Learn about strategies to combat β-lactamases
Evaluate the development of precision antibiotics: Agents designed to meet the demands of stewardship
Explore the role of plasmids in the evolution of antimicrobial resistance

Join us in London next year to explore the challenges and solutions to the growing threat of antibiotic resistance, as well as take part in interactive roundtable discussions with leading organisations. Attendees will also have the exclusive opportunity of networking with an unrivalled gathering of senior experts from Chemical Biology Ventures, University of Oxford, MedImmune, HPRA, GARDP, DNDi, Bioharmony Therapeutics, and many more.
Early Bird Discounts!
Book by November 30th and save £400
Book by December 14th and save £200
Book by January 31st and save £100
For more information and to register online, please visit http://www.superbugssuperdrugs.com/pjwl

2nd Annual Pharma Regulatory Summit 2019
2019-03-14 | Kohinoor Continental Hotel, Mumbai, India, Mumbai, India
Pharma Regulatory Summit is the leading platform for regulatory experts, to be updated with latest country updates and strategies to navigate the complex and ever changing regulations in the region. This conference will focus on the new strategies, amendments, innovations, developments in the fields of regulatory affairs, intellectual property and medical devices, which reflects new strategies in the field of regulatory affairs.
SPONSORS:

Exhibitor: Nishith Desai Associates

CONFERENCE REGISTRATION PROCESS:
E-mail – kavitha@virtueinsight.co.in Tel: +9144 24762472

Early Bird Discount Price (Ends 28th January 2019) – (INR 10,000 + GST (18%) per delegate)
Standard Price (From 29th January 2019 Onwards) – (INR 15,000 + GST (18%) per delegate)
Sponsor, Exhibition Stall (Booth) and a paid Speaker Slots are also available

Get more from the event, with a broader scope bringing the whole communications value chain together.
